PubMed Mentions
The links below are to publications on PubMed referring to PDBP: Parkinson's Disease Biomarkers Program. This list is gathered weekly from PubMed automatically and was last updated on December 17, 2025.
| Publication/References | |
| Assessment of LIN28A variants in Parkinson's disease in large European cohorts. Description: Diez-Fairen, Monica, et al. Assessment of LIN28A variants in Parkinson's disease in large European cohorts. ''Neurobiol Aging''. 2021 Apr; '''100''': 118.e1-118.e3 | |
| Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. Description: Wilkes, Bradley J, et al. Distinct cortical and subcortical predictors of Purdue Pegboard decline in Parkinson's disease and atypical parkinsonism. ''NPJ Parkinsons Dis''. 2023 Jun 5; '''9''' (1):85 | |
| Federated Learning for multi-omics: a performance evaluation in Parkinson's disease. Description: Danek, Benjamin, et al. Federated Learning for multi-omics: a performance evaluation in Parkinson's disease. ''bioRxiv''. 2023 Oct 6; | |
| Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. Description: De Francesco, Silvia, et al. Differential diagnosis of neurodegenerative dementias with the explainable MRI based machine learning algorithm MUQUBIA. ''Sci Rep''. 2023 Oct 13; '''13''' (1):17355 | |
| DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. Description: Appleton, Ellen, et al. DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease. ''Transl Neurodegener''. 2024 Jun 11; '''13''' (1):31 | |
| Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation. Description: Yuan, Yuan, et al. Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation. ''Mol Neurodegener''. 2024 Jun 11; '''19''' (1):47 | |
| Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. Description: Su, Chang, et al. Identification of Parkinson's disease PACE subtypes and repurposing treatments through integrative analyses of multimodal data. ''NPJ Digit Med''. 2024 Jul 9; '''7''' (1):184 | |
| Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson's disease. Description: Wang, Longfei, et al. Peripheral immune cell abundance differences link blood mitochondrial DNA copy number and Parkinson's disease. ''NPJ Parkinsons Dis''. 2024 Nov 14; '''10''' (1):219 | |
| Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease. Description: Eubanks, Elena, et al. Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson's disease. ''Cell Rep''. 2025 May 27; '''44''' (5):115636 | |
| Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression. Description: Higginbotham, Lenora, et al. Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression. ''bioRxiv''. 2025 Jun 13; | |
| Impact of Y chromosome loss on the risk of Parkinson's disease and progression. Description: Wang, Junhao, et al. Impact of Y chromosome loss on the risk of Parkinson's disease and progression. ''EBioMedicine''. 2025 Jul; '''117''': 105769 |